Aspirin Resistance in Trinidad.

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

December 15, 2024

Study Completion Date

December 15, 2024

Conditions
Platelet Dysfunction Due to Drugs
Interventions
DRUG

Aspirin 81Mg Ec Tab

Healthy patients will then undergo at least a 2-week course of 81mg of Bayer Aspirin per oral daily, followed by platelet function testing. The patients will then undergo a washout period of 2 weeks, followed by another 2-week course of 81mg Vazalore Aspirin per oral daily, followed by a second round of platelet function testing.

Trial Locations (1)

00000

The University of the West Indies, Saint Augustine

All Listed Sponsors
lead

The University of The West Indies

OTHER

NCT06228820 - Aspirin Resistance in Trinidad. | Biotech Hunter | Biotech Hunter